The US Food and Drug Administration continues its consideration of whether kratom should be lawful as a dietary ingredient by commissioning an exploratory study of consumers’ decisions about how, where and why they buy products containing the botanical.
In a notice published on 1 August announcing a sole source contract for market research firm Brightfield Group, the...



